FWI
VRTX icon

Facet Wealth Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Facet Wealth Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Sell
476
-140
-23% -$62K ﹤0.01% 362
2026
Q1 		$275K Buy
+616
New +$287K ﹤0.01% 274
2025
Q4 		– Sell
-691
Closed -$271K – 305
2025
Q3 		$271K Buy
691
+158
+30% +$66K 0.01% 174
2025
Q2 		$244K Buy
+533
New +$246K 0.01% 160

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Facet Wealth Inc's VRTX Position: Q2 2026 in Review

Facet Wealth Inc reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q2 2026, selling an estimated $62K and leaving 476 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Facet Wealth Inc first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $275K in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Facet Wealth Inc held 476 shares of Vertex Pharmaceuticals worth $236K as of Q2 2026.
  • Facet Wealth Inc sold 140 Vertex Pharmaceuticals shares in Q2 2026, an estimated $62K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #362 holding.
  • Facet Wealth Inc first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Facet Wealth Inc's Vertex Pharmaceuticals position peaked at $275K in Q1 2026.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.